Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer

NCT05922553 | Recruiting DMC

• 1 other identifier: mukbang RCT
• Study Type: interventional
• Target: 124
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.

Conditions

Children With Cancer

Keywords

Childhood Cancer; Mukbang; Appetite; Nutritional Status; Quality of Life

Outcome Measures

Primary Outcomes (2)

• Self-reported appetite during the intervention

  A subjective sensation that stimulates the intake of food to provide the energy necessary for the most basic activities of life, which can be measured by the Cancer Appetite and Symptom Questionnaire (CASQ).

  Change from baseline appetite during 7 days intervention

• Self-reported appetite during the intervention

  A subjective sensation that stimulates the intake of food to provide the energy necessary for the most basic activities of life, which can be measured by the Cancer Appetite and Symptom Questionnaire (CASQ).

  Change from baseline appetite at 4 weeks follow-up

Secondary Outcomes (6)

• The level of nutritional status

  Change from baseline nutritional status at 7 days

• The level of nutritional status

  Change from baseline nutritional status at 4-weeks follow-up

• The level of the body mass index of the children with cancer

  Change from baseline BMI at 7 days

• The level of the body mass index of the children with cancer

  Change from baseline BMI at 4-weeks follow-up

• The quality of life after the intervention

  Change from baseline quality of life at 7 days

Study Arms (2)

Active Ingredient Mukbang

EXPERIMENTAL

Active Ingredient Mukbang will be allocated to the participants in the experimental group. The videos which presented the food images, eating sound and a relaxing and pleasant atmosphere will be sent in sequence through the short video platforms on the smart phone to the participants in the experimental group.

Behavioral: Active Ingredient Mukbang

General short videos

PLACEBO COMPARATOR

General short videos without food cues will be allocated to the participants in the placebo control group. There will be no restrictions on the type of short video platforms and specific video content.

Behavioral: General short videos

Interventions

Active Ingredient Mukbang BEHAVIORAL

Mukbang videos include the items which can truly improve the appetite of children with cancer, such as food images, eating sound and interactivity.

Active Ingredient Mukbang

General short videos BEHAVIORAL

Short videos that don't contain any food cues.

General short videos

Eligibility Criteria

• Age: 6 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Aged between 6 to 18 years old;
• Children in accordance with the guidelines for the Diagnosis and Treatment of 12 Diseases related to hematologic diseases and malignant tumors (2021 version) issued by the General Office of the National Health Commission;
• At least experience one full cycle of chemotherapy;
• Children with moderate or higher symptoms of decreased appetite were screened for a list of treatment-related symptoms.

You may not qualify if:

• Children with serious cardiopulmonary disease, infection, organ damage, or genetic metabolic disease, immune deficiency disease, mental illness;
• Children with eye or ear dysfunction that prevents them from watching and listening to videos.

Sponsors & Collaborators

• Wei XIA, PhD: lead

Study Sites (1)

Sun Yat-sen Memorial Hospital

Guangzhou, Guangdong, 510080, China

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

• Wei Xia, PhD

  Sun Yat-sen University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Wei Xia, PhD

CONTACT

+8618823359471; xiaw23@mail.sysu.edu.cn

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Philosophic Doctor

Study Record Dates

• First Submitted: June 5, 2023
• First Posted: June 28, 2023
• Study Start: December 16, 2024
• Primary Completion: March 1, 2026
• Study Completion (Estimated): June 1, 2026
• Last Updated: August 6, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will share
• Shared Documents: SAP
• Time Frame: After the publication of the study
• Access Criteria: Researchers should contact the PI for approval of the study protocol.

Locations

CN (1)